Reneo Pharmaceuticals, Inc.
RPHM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,699 | -$15,390 | -$15,925 | -$15,332 |
| Dep. & Amort. | $204 | $212 | $212 | $590 |
| Deferred Tax | $0 | $0 | $0 | -$2,779 |
| Stock-Based Comp. | $2,961 | $2,908 | $2,745 | $1,144 |
| Change in WC | $0 | $0 | $0 | $10,562 |
| Other Non-Cash | -$1,503 | -$1,004 | -$1,037 | $2,272 |
| Operating Cash Flow | -$13,037 | -$13,274 | -$14,005 | -$3,543 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$13 | -$18 | -$25 |
| Net Acquisitions | $0 | $0 | $0 | $50 |
| Inv. Purchases | $0 | $0 | $0 | $108,949 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$169,075 |
| Other Inv. Act. | $0 | $0 | $0 | -$50 |
| Investing Cash Flow | -$6 | -$13 | -$18 | -$60,151 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $58,970 |
| Stock Repurch. | $0 | $0 | $0 | $4,403 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$77 | $115,943 |
| Financing Cash Flow | $0 | $0 | -$77 | $120,346 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$13,043 | -$13,287 | -$14,100 | $74,791 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $83,374 | $96,661 | $110,761 | $35,970 |
| End Cash | $70,331 | $83,374 | $96,661 | $110,761 |
| Free Cash Flow | -$13,043 | -$13,287 | -$14,023 | -$3,568 |